![Robert Azelby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 31/05/2026
Robert W.
Azelby is currently an Independent Non-Executive Director at ADC Therapeutics SA since 2023, a Non-Executive Director at Autolus Therapeutics Plc starting in 2024, an Independent Director at Cardinal Health, Inc. beginning in 2024, and an Independent Director at Tango Therapeutics, Inc. from 2026.
Formerly, Mr. Azelby was President, Chief Executive Officer & Director at Lundbeck Seattle BioPharmaceuticals, Inc. from 2018 to 2019, President, Chief Executive Officer & Director at Climb Bio, Inc. from 2020 to 2023, Chief Executive Officer at Masimo Corp.
from 2024 to 2025, Director at Immunomedics, Inc. in 2020, Director at Cascadian Therapeutics LLC from 2017 to 2018, Independent Director at Clovis Oncology, Inc. from 2018 to 2023, Independent Director at Chinook Therapeutics, Inc. in 2023, Independent Director at Terns Pharmaceuticals, Inc. from 2025 to 2026, Vice President & General Manager-Oncology at Amgen, Inc. from 2012 to 2015, VP-Commercial Effectiveness Unit & General Manager at Amgen Europe BV, Chief Commercial Officer & Executive VP at Juno Therapeutics, Inc. from 2015 to 2018, and Director at Alliance for Regenerative Medicine.
Education includes undergraduate studies at the University of Virginia and an MBA from Harvard Business School conferred in 1997.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/11/2025 | 4.085 ( 0% ) | 803 928 $ | 31/05/2026 | |
ADC THERAPEUTICS LTD 0,09% | 03/06/2026 | 112.805 ( 0,09% ) | 383 537 $ | 31/05/2026 |
| 19/06/2026 | 5.740 ( 0% ) | 126 165 $ | 31/05/2026 | |
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ADC THERAPEUTICS SA | Direttore/Membro del Consiglio | 14/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Direttore/Membro del Consiglio | 09/01/2024 |
| CARDINAL HEALTH, INC. | Direttore/Membro del Consiglio | 01/03/2024 |
| TANGO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/06/2026 |
| Società | Posizione | Fine |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 05/05/2026 |
| MASIMO CORPORATION | Amministratore Delegato | 01/02/2025 |
| CHINOOK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 11/08/2023 |
| CLOVIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 10/07/2023 |
| CLIMB BIO, INC. | Amministratore Delegato | 13/02/2023 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 18 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Masimo Corp.
 Masimo Corp. Medical SpecialtiesHealth Technology Designs and manufactures non-invasive patient monitoring devices | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
